Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Review

Publication Year

From

Quick links

Individual year

2023

2022

2014

2012

2009

2008

2007

2005

2003

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""ELAV Proteins""[mesh_terms]

11 Results

Searching titles within these results

Paraneoplastic vs. non-paraneoplastic anti-Hu associated dysmotility: a case series and literature review.

Simone Rossi, Elena Merli, Rita Rinaldi, Gaia Deleonardi, Vincenzo Mastrangelo, Anna Simona Sasdelli, Alessandro Di Federico, Maria Guarino, Vincenzo Donadio, Loris Pironi, Francesco Gelsomino, Roberto De Giorgio, Roberto D'Angelo

Journal of neurology 2022;269(3):1182-1194

Full Text

Abstract

Short- and Long-Term Regulation of HuD: A Molecular Switch Mediated by Folic Acid?

Nicoletta Marchesi, Pasquale Linciano, Lucrezia Irene Maria Campagnoli, Foroogh Fahmideh, Daniela Rossi, Giosuè Costa, Francesca Alessandra Ambrosio, Annalisa Barbieri, Simona Collina, Alessia Pascale

International journal of molecular sciences 2023;24(15):12201

Free Full Text

Abstract

Interplay between microRNAs and RNA-binding proteins determines developmental processes.

Reuven Agami, Martijn Kedde

Cell cycle (Georgetown, Tex.) 2008;7(7):899-903

Full Text

Abstract

Regulation of cyclooxygenase-2 and cytosolic phospholipase A2 gene expression by lipopolysaccharide through the RNA-binding protein HuR: involvement of NADPH oxidase, reactive oxygen species and mitogen-activated protein kinases.

Wei-Ning Lin, Chih-Chung Lin, Hsin-Yi Cheng, Chuen-Mao Yang

British journal of pharmacology 2012;163(8):1691-706

Free Full Text

Abstract

Comparison of the cytokine profiles of patients with neuronal-antibody-associated central nervous system disorders.

Canan Ulusoy, Erdem Tüzün, Murat Kürtüncü, Recai Türkoğlu, Gülşen Akman-Demir, Mefküre Eraksoy

The International journal of neuroscience 2012;122(6):284-9

Full Text

Abstract

Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU-rich elements and auto-Regulation.

Wijdan Al-Ahmadi, Maha Al-Ghamdi, Latifa Al-Haj, Maher Al-Saif, Khalid S A Khabar

Nucleic acids research 2009;37(11):3612-24

Free Full Text

Abstract

Posttranscriptional control of the chemokine receptor CXCR4 expression in cancer cells.

Norah Al-Souhibani, Maha Al-Ghamdi, Wijdan Al-Ahmadi, Khalid S A Khabar

Carcinogenesis 2014;35(9):1983-92

Free Full Text

Abstract

Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma.

Carsten Denkert, Wilko Weichert, Klaus-Jürgen Winzer, Berit-Maria Müller, Aurelia Noske, Silvia Niesporek, Glen Kristiansen, Hans Guski, Manfred Dietel, Steffen Hauptmann

Clinical cancer research : an official journal of the American Association for Cancer Research 2005;10(16):5580-6

Full Text

Abstract

Post-transcriptional regulation of HSP70 expression following oxidative stress in SH-SY5Y cells: the potential involvement of the RNA-binding protein HuR.

M Amadio, G Scapagnini, U Laforenza, M Intrieri, L Romeo, S Govoni, A Pascale

Current pharmaceutical design 2009;14(26):2651-8

Full Text

Abstract

Inhibition of MMP-9 secretion by the anti-metastatic PSP94-derived peptide PCK3145 requires cell surface laminin receptor signaling.

Borhane Annabi, Mounia Bouzeghrane, Jean-Christophe Currie, Hélène Dulude, Luc Daigneault, Seema Garde, Shafaat A Rabbani, Chandra Panchal, Jinzi J Wu, Richard Béliveau

Anti-cancer drugs 2007;17(4):429-38

Full Text

Abstract

Increased AMP:ATP ratio and AMP-activated protein kinase activity during cellular senescence linked to reduced HuR function.

Xiaoling Yang, Wengong Wang, Myriam Gorospe, David Carling, Isabel López de Silanes

The Journal of biological chemistry 2003;278(29):27016-23

Free Full Text

Abstract

Results: 1 – 11 / 11

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""ELAV Proteins""[mesh_terms]

Paraneoplastic vs. non-paraneoplastic anti-Hu associated dysmotility: a case series and literature review.

Short- and Long-Term Regulation of HuD: A Molecular Switch Mediated by Folic Acid?

Interplay between microRNAs and RNA-binding proteins determines developmental processes.

Regulation of cyclooxygenase-2 and cytosolic phospholipase A2 gene expression by lipopolysaccharide through the RNA-binding protein HuR: involvement of NADPH oxidase, reactive oxygen species and mitogen-activated protein kinases.

Comparison of the cytokine profiles of patients with neuronal-antibody-associated central nervous system disorders.

Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU-rich elements and auto-Regulation.

Posttranscriptional control of the chemokine receptor CXCR4 expression in cancer cells.

Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma.

Post-transcriptional regulation of HSP70 expression following oxidative stress in SH-SY5Y cells: the potential involvement of the RNA-binding protein HuR.

Inhibition of MMP-9 secretion by the anti-metastatic PSP94-derived peptide PCK3145 requires cell surface laminin receptor signaling.

Increased AMP:ATP ratio and AMP-activated protein kinase activity during cellular senescence linked to reduced HuR function.

Results for
""ELAV Proteins""[mesh_terms]